FAQ

Myeloid Leukemia

Known as: LEUKEMIA, GRANULOCYTIC, MALIGNANT, Myelocytic Leukemias, Unspecified myeloid leukemia 
A clonal proliferation of myeloid cells and their precursors in the bone marrow, peripheral blood, and spleen. When the proliferating cells are… (More)

Topic mentions per year

Topic mentions per year

1936-2017
010002000300019362016

Related topics

Related topics

43 relations
ABL2 geneABL2 wt AlleleANXA8 geneAcute Promyelocytic Leukemia
(More)

Narrower (8)

Acute myelomonocytic leukemiaEosinophilic leukemiaGranulocytic SarcomaLeukemia, Myelocytic, Acute
(More)

Broader (2)

Neoplasmsleukemia

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Myeloid Leukemia
Neoplasms
cancer cell
leukemia
Leukemia, Myelocytic, Acute
Bone Marrow

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
Myelodysplastic syndrome (MDS) is a clonal blood disorder characterized by ineffective hematopoiesis, cytopenias, dysplasia and… (More)
  • figure 1
  • figure 2
  • table I
  • table II
  • table III
Is this relevant?
Review
2015
Review
2015
Programmed death-1 checkpoint blockade in acute myeloid leukemia.
INTRODUCTION Immune checkpoints are regulatory pathways induced in activated T lymphocytes that regulate antigen responsiveness… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
DNMT3A mutations in acute myeloid leukemia
New studies reveal that 20% of individuals with acute myeloid leukemia harbor somatic mutations in DNMT3A (encoding DNA… (More)
  • figure 1
  • figure 1
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Recurring mutations found by sequencing an acute myeloid leukemia genome.
BACKGROUND The full complement of DNA mutations that are responsible for the pathogenesis of acute myeloid leukemia (AML) is not… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
BACKGROUND Mutations occur in several genes in cytogenetically normal acute myeloid leukemia (AML) cells: the nucleophosmin gene… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.
BACKGROUND The cause of chronic myeloid leukemia (CML) is a constitutively active BCR-ABL tyrosine kinase. Imatinib inhibits this… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.
BACKGROUND Imatinib, a selective inhibitor of the BCR-ABL tyrosine kinase, produces high response rates in patients with chronic… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
BACKGROUND BCR-ABL, a constitutively activated tyrosine kinase, is the product of the Philadelphia chromosome. This enzyme is… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BACKGROUND BCR-ABL is a constitutively activated tyrosine kinase that causes chronic myeloid leukemia (CML). Since tyrosine… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
On the subject of acute myeloid leukemia (AML), there is little consensus about the target cell within the hematopoietic stem… (More)
Is this relevant?